Leading global pharmaceutical company Cipla Ltd approved an investment of $100 million in its wholly owned subsidiary Cipla (EU) and amalgamation of Inzpera Healthsciences Ltd with itself. In a regulatory filing, Cipla said that the investment of $100 million in Cipla (EU) will be utilised for onward financial assistance to InvaGen Pharmaceuticals Inc. towards capital […]